Marguet; Frank

Patent Applications and Registrations

Patent applications and USPTO patent grants for Marguet; Frank.The latest application filed is for "modified relaxin b chain peptides and their therapeutic use".

Company Profile

4.13.17

Marguet; Frank - Paris FR
Marguet; Frank - Verrieres le Buisson FR
MARGUET; Frank - Verrieres Le Buissont FR
Marguet; Frank - Verrieres le Buission FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Modified lipidated Relaxin B chain peptides and their therapeutic use Grant 10,988,523 - Brasseur , et al. April 27, 2	2021-04-27
Modified relaxin B chain peptides and their therapeutic use Grant 10,988,524 - Illiano , et al. April 27, 2	2021-04-27
Modified Lipidated Relaxin B Chain Peptides And Their Therapeutic Use App 20190233493 - Brasseur; Denis ; et al.	2019-08-01
Modified Relaxin B Chain Peptides And Their Therapeutic Use App 20190233495 - ILLIANO; Stephane ; et al.	2019-08-01
Use Of 7-chloro-n,n,5-trimethyl-4-oxo-3-phenyl-3,5-dihydro-4h-pyridazino[4- ,5-b] Indole-1-acetamide As A Biomarker Of Peripheral Benzodiazepine Receptor Levels App 20170160287 - BENAVIDES; Jesus ; et al.	2017-06-08
3,4-dihydropyrrolo[1,2-A]pyrazine-2,8(1H)-dicarboxamide derivatives, preparation thereof and therapeutic use thereof for diseases involving casein kinase 1 epsilon and/or casein kinase 1 delta Grant 9,233,965 - Cote-Des-Combes , et al. January 12, 2	2016-01-12
3,4-dihydropyrrolo[1,2-a]pyrazine-2,8(1h)-dicarboxamide Derivatives, Preparation Thereof And Therapeutic Use Thereof App 20140336189 - COTE-DES-COMBES; Sylvain ; et al.	2014-11-13
Hexafluoroisopropyl carbamate derivatives, their preparation and their therapeutic application Grant 8,835,418 - Bartsch , et al. September 16, 2	2014-09-16
3,4-dihydropyrrolo[1,2-A]pyrazine-2,8(1H)-dicarboxamide derivatives, preparation thereof and therapeutic use thereof for diseases involving casein kinase 1 epsilon and/or casein kinase 1 delta Grant 8,791,119 - Des Combes , et al. July 29, 2	2014-07-29
3,4-dihydropyrrolo[1,2-a]pyrazine-2,8(1h)-dicarboxamide Derivatives, Preparation Thereof And Therapeutic Use Thereof App 20130090340 - COTE-DES-COMBES; Sylvain ; et al.	2013-04-11
Use Of 7-chloro-n,n,5-trimethyl-4-oxo-3-phenyl-3,5-dihydro-4h-pyridazino[4- ,5-b] Indole-1-acetamide As A Biomarker Of Peripheral Benzodiazepine Receptor Levels App 20120039816 - Benavides; Jesus ; et al.	2012-02-16
3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]indole-1-carboxamide Derivatives, Their Preparation And Therapeutic Use App 20090275576 - BURNIER; Philippe ; et al.	2009-11-05
1H-Pyrimido[4,5-b]indole Derivatives, Their Preparation and Therapeutic Use App 20090215741 - FROISSANT; Jacques ; et al.	2009-08-27
3-Heteroaryl-3,5-dihydro-4-oxo-4H-pyridazino[4,5-B]indole-1-carboxamide derivatives, their preparation and therapeutic use Grant 7,569,567 - Burnier , et al. August 4, 2	2009-08-04
1H-pyrimido[4,5-b]indole derivatives, their preparation and therapeutic use Grant 7,547,706 - Froissant , et al. June 16, 2	2009-06-16
3-Heteroaryl-3,5-dihydro-4-oxo-4H-pyridazino[4,5-b]indole-1-acetamide derivatives, their preparation and their application in therapeutics App 20080255129 - FROISSANT; Jacques ; et al.	2008-10-16
3-Heteroaryl-3,5-dihydro-4-oxo-4H-pyridazino[4,5-B]indole-1-carboxamide Derivatives, Their Preparation and Therapeutic Use App 20080249098 - Burnier; Philippe ; et al.	2008-10-09
3-Heteroaryl-3,5-dihydro-4-oxo-4H-pyridazino[4,5-b]indole-1-acetamide derivatives, their preparation and their application in therapeutics Grant 7,405,306 - Froissant , et al. July 29, 2	2008-07-29
3-heteroaryl-3,5-dihydro-4-oxo-4H-pyridazino[4,5-B]indole-1-carboxamide derivatives, their preparation and therapeutic use Grant 7,402,682 - Burnier , et al. July 22, 2	2008-07-22
1H-Pyrimido[4,5-b]indole derivatives, their preparation and therapeutic use App 20080125410 - Froissant; Jacques ; et al.	2008-05-29
3-Heteroaryl-3,5-dihydro-4-oxo-4H-pyridazino[4,5-b]indole-1-acetamide derivatives, their preparation and their application in therapeutics App 20080076775 - FROISSANT; Jacques ; et al.	2008-03-27
3-heteroaryl-3,5-dihydro-4-oxo-4H-pyridazino[4,5-b]indole-1-acetamide derivatives, their preparation and their application in therapeutics Grant 7,323,467 - Froissant , et al. January 29, 2	2008-01-29
3-Heteroaryl-3,5-dihydro-4-oxo-4H-pyridazino[4,5 b]indole-1-acetamide derivatives, their preparation and their application in therapeutics App 20070219202 - FROISSANT; Jacques ; et al.	2007-09-20
3-heteroaryl-3,5-dihydro-4-oxo-4H-pyridazino[4,5-b] indole-1-acetamide derivatives, preparation and use thereof in medicaments Grant 7,235,554 - Froissant , et al. June 26, 2	2007-06-26
Aryl- And Heteroarylpiperidinecarboxylate-derivatives Methods For Their Preparation And Use Thereof As Fatty Acid Amido Hydrolase Enzyme Inhibitors App 20070021405 - ABOUABDELLAH; Ahmed ; et al.	2007-01-25
3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]indole-1-carboxamide Derivatives, Their Preparation And Therapeutic Use App 20060241116 - BURNIER; Philippe ; et al.	2006-10-26
3-heteroaryl-3, 5-dihydro-4-oxo-4H-pyridazino[4, 5-b]indole-1-carboxamide derivatives their preparations and therapeutic use Grant 7,109,194 - Burnier , et al. September 19, 2	2006-09-19
3-heteroarly-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b] indole-1-acetamide derivatives, preparation and use thereof in medicaments App 20050124615 - Froissant, Jacques ; et al.	2005-06-09
3-heteroaryl-3, 5-dihydro-4-oxo-4H-pyridazino[4, 5-b]indole-1-carboxamide derivatives their preparations and therapeutic use App 20050096321 - Burnier, Philippe ; et al.	2005-05-05
4-oxo-3,5-dihydro-4H-pyridazino[4,5-b]indole-1-carboxamide derivatives, preparation and therapeutic use Grant 6,451,795 - Marguet , et al. September 17, 2	2002-09-17

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.